U.K. is urged to probe drugmakers for conspiring to scrap or halt investments amid pricing disputes

Taking stock of the drug industry, from the lab to the medicine chest

October 1, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Kirsty Wigglesworth/AP STAT+ | U.K. is urged to probe drugmakers for conspiring to scrap or halt investments amid pricing disputes The move comes as President Trump has demanded drugmakers cut prices in the U.S. to bring them in line with those in Europe and Canada By Ed Silverman STAT+ | Will the White House drug-pricing deal lower costs for Americans? Experts are skeptical Trump described his administration's deal with Pfizer as historic. Experts aren't so sure it will lower consumer costs. By Elaine Chen STAT+ | Trump administration backs off 100% pharma tariffs threatened to start today A White House official told STAT that the tariffs have not gone into effect and that the administration would now "begin preparing" them. By Daniel Payne Courtesy Nicholas Roznovsky Leucovorin has a place in autism treatment, researcher says, but he tamps down parents' expectations Retired UCSF researcher Robert Hendren says leucovorin has a place in ASD treatment, but notes studies failed to show a 'remarkable' response By O. Rose Broderick

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser